The dynamic loss and gain of BCR clonotypes as well as SNV-defined subclones could be indicative of differences in the selection pressure mediated by the tumor microenvironment, including the strength of antitumor immune responses during the course of CLL. This evidence concerns the gene BCR and neoplasm.